Hematologic Neoplasms Clinical Trials

A listing of Hematologic Neoplasms medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

UPDATED

Los Angeles California 90027

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

UPDATED

Palo Alto California 94304

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

District of Columbia

UPDATED

Washington District of Columbia 20010

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

Georgia

UPDATED

Atlanta Georgia 30322

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

Massachusetts

UPDATED

Boston Massachusetts 02215

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

New York

UPDATED

Bronx New York 10467

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

UPDATED

New York New York 10029

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

New York New York 10065

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Oregon

UPDATED

Portland Oregon 97239

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

Texas

UPDATED

Dallas Texas 77390

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

UPDATED

Houston Texas 77030

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

Washington

UPDATED

Seattle Washington 98109

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

Israel

UPDATED

Haifa 31096

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

Jeursalem 91120

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

Ramat Gan 57261

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

Tel Aviv 64239

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Poland

UPDATED

Krakow 30-510

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Spain

UPDATED

Barcelona 08035

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

Barcelona 08036

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

Madrid 28040

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

Madrid 28007

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

UPDATED

Salamanca 37007

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies